Iovance Biotherapeutics, Inc. Share

Iovance Biotherapeutics, Inc. (IOVA) is a biopharmaceutical company focused on developing and commercializing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL). TIL therapy harnesses the power of a patient's own immune system to target and destroy cancer cells. Iovance's research and development efforts are centered on advancing TIL therapies for various solid tumors and hematologic malignancies. The company is committed to addressing unmet medical needs in oncology by pioneering innovative approaches to cancer treatment. Iovance's work involves the isolation, expansion, and activation of TIL cells from a patient's tumor, followed by their re-infusion back into the patient to fight the cancer. This personalized approach aims to provide durable and effective responses for patients with advanced cancers.